SU 4312

Discontinued Product

1459 has been discontinued.

View all VEGFR products.
Description: Potent inhibitor of VEGFR tyrosine kinase
Alternative Names: DMBI
Chemical Name: 3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one
Datasheet
Citations (1)
Reviews
Literature (1)
Pathways (1)

Biological Activity for SU 4312

SU 4312 is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). Selective over EGFR and c-Src tyrosine kinases.

Technical Data for SU 4312

M. Wt 264.33
Formula C17H16N2O
Storage Desiccate at -20°C
CAS Number 5812-07-7
PubChem ID 6450842
InChI Key UAKWLVYMKBWHMX-PTNGSMBKSA-N
Smiles CN(C)C1=CC=C(C=C1)\C=C1/C(=O)NC2=CC=CC=C12

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

View Related Products by Product Action

View all VEGFR Inhibitors

Keywords: SU 4312, SU 4312 supplier, Potent, inhibitors, inhibits, VEGFR, tyrosine, kinase, Vascular, Endothelial, Growth, Factor, Receptors, KDR, Flt, Receptor, Tyrosine, Kinases, RTKs, SU4312, DMBI, 1459, Tocris Bioscience

1 Citation for SU 4312

Citations are publications that use Tocris products. Selected citations for SU 4312 include:

Cole et al (2010) Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. PLoS One 5 e11644 PMID: 20657775


Reviews for SU 4312

There are currently no reviews for this product. Be the first to review SU 4312 and earn rewards!

Have you used SU 4312?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.

Pathways for SU 4312

VEGF Signaling Pathway

VEGF Signaling Pathway

VEGF signaling pathway is involved in embryonic vascular development (vasculogenesis) and in the formation of new blood vessel (angiogenesis). It also induces cell migration, proliferation and survival.